The DOI matches its Crossref record.
Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus
Abstract
Treatment outcome of experimental device-related infections cannot be predicted by the results of standard susceptibility tests such as MIC. Microorganisms involved in such infections have a slow growth rate and adhere to surfaces. Therefore, laboratory tests were developed taking into account these properties and compared with the treatment outcome in an animal model. Vancomycin, teicoplanin, ciprofloxacin and fleroxacin were tested alone, or in combination with rifampicin for their ability to cure experimental device-related infections in guinea pigs due to Staphylococcus aureus ATCC 29213. Rifampicin alone or in combination was significantly more effective than the other four drugs (P < 0.001). Combined treatment with rifampicin had a higher cure rate than rifampicin alone. Treatment success was not predicted by an antibiotic trough level exceeding the MIC at site of infection. In contrast, drug efficacy was predicted if the stationary-phase MBC was in the sensitive range, and if glass-adherent S. aureus was killed by low drug concentrations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
Zimmerli, W., Trampuz, A., & Ochsner, P. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmra040181 · Cited by 3,116
Zimmerli, W. (1998) · JAMA · doi:10.1001/jama.279.19.1537 · Cited by 1,079
Predictors of Mortality in Staphylococcus aureus Bacteremia
van Hal, S. J., Jensen, S. O., Vaska, V. L., Espedido, B. A., Paterson, D. L., & Gosbell, I. B. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05022-11 · Cited by 932
Rex, J. H., Pfaller, M. A., Galgiani, J. N., Bartlett, M. S., Espinel-Ingroff, A., Ghannoum, M. A., Lancaster, M., Odds, F. C., Rinaldi, M. G., Walsh, T. J., et al. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.2.235 · Cited by 855
Infections associated with orthopedic implants
Trampuz, A., & Widmer, A. F. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000235161.85925.e8 · Cited by 542
Clinical presentation and treatment of orthopaedic implant‐associated infection
Zimmerli, W. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12233 · Cited by 481
Prosthetic joint infections: update in diagnosis and treatment
Trampuz, A., & Zimmerli, W. (2005) · Swiss Medical Weekly · doi:10.4414/smw.2005.10934 · Cited by 424
Byren, I., Bejon, P., Atkins, B. L., Angus, B., Masters, S., McLardy-Smith, P., Gundle, R., & Berendt, A. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp107 · Cited by 407
Pathogenesis and treatment concepts of orthopaedic biofilm infections
Zimmerli, W., & Moser, C. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00938.x · Cited by 343
Orthopaedic biofilm infections
Zimmerli, W., & Sendi, P. (2017) · APMIS · doi:10.1111/apm.12687 · Cited by 338
Global spread of three multidrug-resistant lineages of Staphylococcus epidermidis
Lee, J. Y. H., Monk, I. R., Gonçalves da Silva, A., Seemann, T., Chua, K. Y. L., Kearns, A., Hill, R., Woodford, N., Bartels, M. D., Strommenger, B., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0230-7 · Cited by 299
Prosthetic-joint-associated infections
Zimmerli, W. (2006) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2006.08.003 · Cited by 256
Senneville, E., Joulie, D., Legout, L., Valette, M., Dezeque, H., Beltrand, E., Rosele, B., d'Escrivan, T., Loiez, C., Caillaux, M., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir402 · Cited by 255
Metadata
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 1994
- Volume
- 33
- Issue
- 5
- Pages
- 959-967
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W87013843
- Cited by
- 192
- References
- 0
- FWCI
- 2.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.